GlassScriptPhysician profile
Sandra Gutierrez
NPI 1669937256
$6,880.88
in general payments reported to CMS, 2019-2025
27 companies · $990 in 2025
The $990 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $526 · 2022: $1,663 · 2023: $2,741 · 2024: $961 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,930 · Travel and Lodging: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,929.93 |
| Travel and Lodging | $761.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,451.97 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $876.20 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $791.07 | 2022-2025 | Interstim, Altaviva |
| Calyxo, INC. | $446.44 | 2023-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $393.59 | 2021-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $352.28 | 2021-2023 | |
| Antares Pharma, INC. | $232.62 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| 180 Medical, INC. | $197.67 | 2021-2025 | Cure Catheter |
| Progenics Pharmaceuticals, INC. | $176.89 | 2022-2023 | Pylarify |
| Merck Sharp & Dohme LLC | $159.79 | 2022-2024 | Keytruda, Lynparza |
| Urovant Sciences INC | $120.48 | 2021-2022 | |
| Procept Biorobotics Corporation | $109.92 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Ferring Pharmaceuticals INC. | $99.98 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $87.58 | 2022-2024 | Bracanalysis Cdx, Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $76.97 | 2021-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $46.12 | 2022-2024 | |
| Abc Home Medical Supply, INC. | $37.16 | 2025 | |
| Tolmar, INC. | $35.48 | 2023 | |
| Ambu INC. | $34.21 | 2024 | |
| Pfizer INC. | $33.98 | 2025 | |
| Novartis Pharmaceuticals Corporation | $28.51 | 2024 | |
| Telix Pharmaceuticals | $25.81 | 2023 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $17.66 | 2022 | |
| Endo USA, INC. | $15.53 | 2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $15.10 | 2025 | |
| Amgen INC. | $12.93 | 2022 | |
| Janssen Biotech, INC. | $4.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.